HK1137807A1 - Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure - Google Patents

Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure

Info

Publication number
HK1137807A1
HK1137807A1 HK10101319.0A HK10101319A HK1137807A1 HK 1137807 A1 HK1137807 A1 HK 1137807A1 HK 10101319 A HK10101319 A HK 10101319A HK 1137807 A1 HK1137807 A1 HK 1137807A1
Authority
HK
Hong Kong
Prior art keywords
airways
infections
diagnosis
heart failure
inflammatory diseases
Prior art date
Application number
HK10101319.0A
Other languages
English (en)
Chinese (zh)
Inventor
‧貝格曼
‧莫根塔勒
‧帕帕佐蒂裡奧
‧施特魯克
Original Assignee
有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39134486&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1137807(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 有限公司 filed Critical 有限公司
Publication of HK1137807A1 publication Critical patent/HK1137807A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/585—Calcitonins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HK10101319.0A 2006-10-01 2010-02-05 Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure HK1137807A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006046996A DE102006046996A1 (de) 2006-10-01 2006-10-01 Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz
PCT/DE2007/001759 WO2008040328A2 (de) 2006-10-01 2007-10-01 Diagnose von infektionen oder entzündungserkrankungen der atemwege und lunge assoziiert mit herzinsuffizienz

Publications (1)

Publication Number Publication Date
HK1137807A1 true HK1137807A1 (en) 2010-08-06

Family

ID=39134486

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10101319.0A HK1137807A1 (en) 2006-10-01 2010-02-05 Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure

Country Status (8)

Country Link
US (1) US8465941B2 (xx)
EP (1) EP2084545B1 (xx)
JP (2) JP5058263B2 (xx)
CN (1) CN101553733B (xx)
DE (1) DE102006046996A1 (xx)
ES (1) ES2455168T3 (xx)
HK (1) HK1137807A1 (xx)
WO (1) WO2008040328A2 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1882945A1 (en) * 2006-07-28 2008-01-30 F.Hoffmann-La Roche Ag Means and methods for the differentiation of cardiac and pulmonary causes of acute shortness of breath
DE102006060112A1 (de) * 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
DE102007009751A1 (de) 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
DE102007021443A1 (de) * 2007-05-08 2008-11-13 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels NT-proET-1
EP2293076B1 (en) * 2007-08-03 2012-12-19 B.R.A.H.M.S GmbH Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
EP2141499A1 (en) * 2008-07-02 2010-01-06 Apoptec AG COPD diagnosis
EP2318844A1 (en) * 2008-07-14 2011-05-11 Roche Diagnostics GmbH Multimarker panel for diagnosing, monitoring and selecting the therapy for patients with heart failure
PT2419741T (pt) 2009-04-14 2019-11-04 Brahms Gmbh Avaliação de risco para tratamento com antibióticos em pacientes que sofrem de doença não infeciosa primária através da determinação do nível de procalcitonina
CN102449486B (zh) * 2009-06-05 2015-01-21 B.R.A.H.M.S有限公司 在患有呼吸困难的对象中检测细菌感染
CN102472752B (zh) 2009-08-28 2015-08-19 B.R.A.H.M.S有限公司 用于不良事件的预后的降钙素原
CN103328976B (zh) * 2010-11-01 2016-08-10 B.R.A.H.M.S有限公司 具有非特定主诉的患者的预后和风险评估
EP2637023A1 (en) * 2012-03-08 2013-09-11 B.R.A.H.M.S GmbH Prediction of outcome in patients with chronic obstructive pulmonary disease
BR112014025189B1 (pt) * 2012-04-12 2020-04-07 Brahms Gmbh métodos de predizer o risco de adquirir um evento adverso e de orientação de tratamento com antibióticos em um paciente com insuficiência cardíaca crônica estável
JP2015089364A (ja) * 2013-11-07 2015-05-11 有限会社ジェノテックス 体細胞多重変異によるがん診断方法、がん医薬開発方法及びがん診断装置
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
EP3438668A1 (en) * 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
WO2021204984A1 (en) 2020-04-09 2021-10-14 B.R.A.H.M.S Gmbh Biomarkers for the diagnosis of respiratory tract infections
US11287396B2 (en) 2020-06-05 2022-03-29 Princeton Biochemicals, Inc. Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease
JPWO2022176287A1 (xx) * 2021-02-18 2022-08-25
EP4357778A1 (en) 2022-10-20 2024-04-24 Heraeus Medical GmbH Treatment of microbial infections diagnosed using the biomarker d-lactate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227454C1 (de) 1992-08-19 1994-02-03 Henning Berlin Gmbh Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens
DE19600875C1 (de) * 1996-01-12 1997-06-26 Brahms Diagnostica Gmbh Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse
DE19847690A1 (de) 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
DE10027954A1 (de) 1999-12-22 2001-06-28 Dade Behring Marburg Gmbh Humanes Procalcitonin, dessen Herstellung und Verwendung
ES2280170T3 (es) 1999-12-22 2007-09-16 Dade Behring Marburg Gmbh Soluciones de procalcitonina humana.
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
EP1628136A1 (en) * 2004-08-19 2006-02-22 B.R.A.H.M.S. Aktiengesellschaft Method of diagnosis of disease using copeptin
DE102006053442A1 (de) * 2006-11-12 2008-05-15 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Infektionen und chronischen Erkrankungen der Atemwege und Lunge mittels proVasopressin, insbesondere Copeptin oder Neurophysin II
DE102007021443A1 (de) * 2007-05-08 2008-11-13 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels NT-proET-1

Also Published As

Publication number Publication date
JP5663531B2 (ja) 2015-02-04
WO2008040328A2 (de) 2008-04-10
JP2012185187A (ja) 2012-09-27
DE102006046996A1 (de) 2008-04-03
CN101553733B (zh) 2014-02-26
ES2455168T3 (es) 2014-04-14
JP5058263B2 (ja) 2012-10-24
EP2084545A2 (de) 2009-08-05
JP2010506146A (ja) 2010-02-25
WO2008040328A3 (de) 2008-06-05
CN101553733A (zh) 2009-10-07
EP2084545B1 (de) 2014-02-12
US8465941B2 (en) 2013-06-18
US20100047835A1 (en) 2010-02-25

Similar Documents

Publication Publication Date Title
HK1137807A1 (en) Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure
PL2170848T3 (pl) Pochodne pirazynonu i ich zastosowanie w leczeniu chorób płuc
IL222542A (en) Use of a compound to prepare a drug to inhibit and diagnose proteinuria in the lung
PL2379088T3 (pl) Leczenie płuca oraz chorób i zaburzeń płucnych
EP2005168A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING DISEASES OF AORTA
EP2019965A4 (en) DIAGNOSTIC METHODS FOR PULMONARY AND / OR CARDIOVASCULAR DISEASE
FR2921499B1 (fr) Structure orientable de type catheter ou endoscope
IL204723A0 (en) Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases
IL186749A0 (en) Dihydrothienopyrimidines for the treatment of inflammatory diseases
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL166183A0 (en) Novel diagnostic and imaging techniques of the gi tract
IL193604A (en) Use of human anti-22 @ il antibodies for @ preparation
EP2440196A4 (en) TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY ADMINISTRATION OF BETA 2 NEBULIZED AGONIST OR A COMBINATION OF BETA 2 NEBULIZED AGONIST AND ANTICHOLINERGIC
EP2164505A4 (en) TREATMENT OF CHRONIC LUNG DISEASE
EP2021016A4 (en) CXCL13 ANTAGONISTS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY DISEASES
NO20054180D0 (no) Behandling av bakterielle sykdommer i andedrettsorganene ved lokal tilforsel av fluorkinoloner
ZA201002989B (en) New antibodies specific of the beta-amyloid and their uses as diagnostic agents or drugs
EP1962869A4 (en) TREATMENT OF RESPIRATORY DISEASES
EP2086646A4 (en) NOSE CATHETER WITH INTERNAL AND EXTERNAL AIR FLOWS
HK1166016A1 (en) The use of glucan on upper respiratory tract infection symptoms and psychological well being
BRPI0721783A2 (pt) "meio multicamada carregado e respirador"
EP2555785B8 (en) Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract
PL2251016T3 (pl) Miejscowe zastosowanie kwasu hialuronowego o działaniu filmotwórczym do leczenia i profilaktyki schorzeń dróg oddechowych
EP2170932A4 (en) COMPOSITIONS AND APPLICATIONS THEREOF IN THE TREATMENT OF ACUTE ATOMIC SYNDROME (ARDS) AND ASSOCIATED CLINICAL ILLNESSES
EP1843781A4 (en) COMPOSITION FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF INFLAMMATORY CHRONIC DISEASES OF AIRWAYS